We first reported that Beclin 1 was unrelated to all clinicopathological parameters in patients with CRC with wild type KRAS, whereas the expression of LC3 was related to TNM stage III/IV in the same subgroup. The gene discussed is MAP1LC3A; the disease is colorectal carcinoma.